Obstructive sleep apnea (OSA) was linked to a more than twofold risk of developing age-related macular degeneration (AMD) in ...

The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...

Sleep apnea, a widespread health issue, causes breathing interruptions during sleep, leading to oxygen deprivation and ...

The magnitude was much greater in children than adults, and central sleep apnea was tied to greater risk than obstructive ...

The European Medicines Agency said on Friday Eli Lilly's weight-loss drug Mounjaro does not need a separate approval for the ...

Medical technology company Nyxoah has officially launched its Genio system, a small implant that has the potential to treat ...

A recent study published in the Journal Children found that nocturnal enuresis is significantly prevalent in children with ...

A good night’s rest is vital to our overall health, but there’s a lot that can interrupt the 7 hours of sleep recommended for ...

This study aims to evaluate the quantity, types, and trends of surgical procedures used to treat obstructive sleep apnea (OSA) within a diverse national population, utilizing a comprehensive ...

A small electronic implant is offering hope to millions of people worldwide who suffer from obstructive apnea, a disorder ...

Treatment with GLP-1RAs was associated with significant improvements in obstructive sleep apnea-related health outcomes.

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...